CXCL8 and metastatic neoplasm: To test whether our above findings in NSCLC and pre-osteoclast cells are clinically relevant, we examined the levels of IL-8 in a cohort of human NSCLC primary tumors (n = 45), non-tumorous adjacent tissues (n = 45) and bone metastatic tumors (n = 15).